3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
15
Vitamin D Deficiency
13
Prostatic Neoplasms
13
Polycystic Ovary Syndrome
8
Neoplasms
7
Osteoporosis
4
Colorectal Neoplasms
4
Warts
3
Rectal Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Colonic Neoplasms
3
Brain Neoplasms
3
Male Urogenital Diseases
2
Leukemia
2
Cardiovascular Diseases
2
Adenomatous Polyps
2
Stroke
1
Spinal Cord Injuries
1
Skin Neoplasms
1
Seizures
1
Psoriasis
1
Prostate Adenocarcinoma
1
Premature Birth
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Pathologic Processes
1
Pain
1
Osteoarthritis
1
Interventions
relacorilant
4
Resistance Training
3
Pioglitazone
3
Dipeptidyl-Peptidase IV Inhibitors
3
Sulfonylurea Compounds
2
Rosiglitazone
2
Nutritional Status
2
Metformin
2
voglibose
1
saxagliptin
1
repaglinide
1
pembrolizumab
1
miglitol
1
metahexamide
1
meglitinide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
empagliflozin
1
Vildagliptin
1
Troglitazone
1
Tolbutamide
1
Tolazamide
1
Thiazolidinediones
1
Surveys and Questionnaires
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sitagliptin Phosphate
1
Resistant Starch
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diabetes Mellitus, Type 2
×
Cholecalciferol
×
Clear all
NCT01463813
2018-10-23
FIND
University of Eastern Finland
Phase NA
Completed
2,495 enrolled